Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
Study NCT ID:
NCT01208051
Status:
COMPLETED
Last Update Posted:
2021-07-15
First Post:
2010-09-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-22
First Submit QC Date:
None
Study First Post Date:
2010-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-22
Results First Submit QC Date:
None
Results First Post Date:
2021-07-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-24
Last Update Post Date:
2021-07-15
Last Update Post Date Type:
ACTUAL